Reducing fund duplication
Considering biotech funds
Following calls to 'sell everything' last month as markets continue to flirt with bear territory, industry experts tell Investment Week where they remain invested, the areas to avoid and, most importantly, why the market slowdown is not a new crisis in...
Rosemary Banyard wins Outstanding Contribution award